146 related articles for article (PubMed ID: 32086105)
1. Indoxyl Sulfate Contributes to Uremic Sarcopenia by Inducing Apoptosis in Myoblasts.
Rodrigues GGC; Dellê H; Brito RBO; Cardoso VO; Fernandes KPS; Mesquita-Ferrari RA; Cunha RS; Stinghen AEM; Dalboni MA; Barreto FC
Arch Med Res; 2020 Jan; 51(1):21-29. PubMed ID: 32086105
[TBL] [Abstract][Full Text] [Related]
2. The double-edged sword of endoplasmic reticulum stress in uremic sarcopenia through myogenesis perturbation.
Jheng JR; Chen YS; Ao UI; Chan DC; Huang JW; Hung KY; Tarng DC; Chiang CK
J Cachexia Sarcopenia Muscle; 2018 Jun; 9(3):570-584. PubMed ID: 29380555
[TBL] [Abstract][Full Text] [Related]
3. Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1.
Enoki Y; Watanabe H; Arake R; Sugimoto R; Imafuku T; Tominaga Y; Ishima Y; Kotani S; Nakajima M; Tanaka M; Matsushita K; Fukagawa M; Otagiri M; Maruyama T
Sci Rep; 2016 Aug; 6():32084. PubMed ID: 27549031
[TBL] [Abstract][Full Text] [Related]
4. Effect of uremic toxin-indoxyl sulfate on the skeletal system.
Liu WC; Wu CC; Lim PS; Chien SW; Hou YC; Zheng CM; Shyu JF; Lin YF; Lu KC
Clin Chim Acta; 2018 Sep; 484():197-206. PubMed ID: 29864403
[TBL] [Abstract][Full Text] [Related]
5. Potential therapeutic interventions for chronic kidney disease-associated sarcopenia via indoxyl sulfate-induced mitochondrial dysfunction.
Enoki Y; Watanabe H; Arake R; Fujimura R; Ishiodori K; Imafuku T; Nishida K; Sugimoto R; Nagao S; Miyamura S; Ishima Y; Tanaka M; Matsushita K; Komaba H; Fukagawa M; Otagiri M; Maruyama T
J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):735-747. PubMed ID: 28608457
[TBL] [Abstract][Full Text] [Related]
6. Methylglyoxal Induces Inflammation, Metabolic Modulation and Oxidative Stress in Myoblast Cells.
Todoriki S; Hosoda Y; Yamamoto T; Watanabe M; Sekimoto A; Sato H; Mori T; Miyazaki M; Takahashi N; Sato E
Toxins (Basel); 2022 Apr; 14(4):. PubMed ID: 35448872
[TBL] [Abstract][Full Text] [Related]
7. Uraemic toxins impair skeletal muscle regeneration by inhibiting myoblast proliferation, reducing myogenic differentiation, and promoting muscular fibrosis.
Alcalde-Estévez E; Sosa P; Asenjo-Bueno A; Plaza P; Olmos G; Naves-Díaz M; Rodríguez-Puyol D; López-Ongil S; Ruiz-Torres MP
Sci Rep; 2021 Jan; 11(1):512. PubMed ID: 33436654
[TBL] [Abstract][Full Text] [Related]
8. Indoxyl sulfate induces myotube atrophy by ROS-ERK and JNK-MAFbx cascades.
Changchien CY; Lin YH; Cheng YC; Chang HH; Peng YS; Chen Y
Chem Biol Interact; 2019 May; 304():43-51. PubMed ID: 30849338
[TBL] [Abstract][Full Text] [Related]
9. Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease.
Sato E; Mori T; Mishima E; Suzuki A; Sugawara S; Kurasawa N; Saigusa D; Miura D; Morikawa-Ichinose T; Saito R; Oba-Yabana I; Oe Y; Kisu K; Naganuma E; Koizumi K; Mokudai T; Niwano Y; Kudo T; Suzuki C; Takahashi N; Sato H; Abe T; Niwa T; Ito S
Sci Rep; 2016 Nov; 6():36618. PubMed ID: 27830716
[TBL] [Abstract][Full Text] [Related]
10. Uremic toxins enhance statin-induced cytotoxicity in differentiated human rhabdomyosarcoma cells.
Uchiyama H; Tsujimoto M; Shinmoto T; Ogino H; Oda T; Yoshida T; Furukubo T; Izumi S; Yamakawa T; Tachiki H; Minegaki T; Nishiguchi K
Toxins (Basel); 2014 Sep; 6(9):2612-25. PubMed ID: 25192420
[TBL] [Abstract][Full Text] [Related]
11. Indoxyl sulfate inhibits muscle cell differentiation via Myf6/MRF4 and MYH2 downregulation.
Bataille S; McKay N; Koppe L; Beau A; Benoit B; Bartoli M; Da Silva N; Poitevin S; Aniort J; Chermiti R; Burtey S; Dou L
Nephrol Dial Transplant; 2023 Dec; 39(1):103-113. PubMed ID: 37349959
[TBL] [Abstract][Full Text] [Related]
12. Effects of N-acetyl-L-tryptophan on desorption of the protein-bound uremic toxin indoxyl sulfate and effects on uremic sarcopenia.
Ohashi A; Nakatani M; Hori H; Nakai S; Tsuchida K; Hasegawa M; Tsuboi N
Ther Apher Dial; 2023 Dec; 27(6):1023-1027. PubMed ID: 37596835
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the effects of indoxyl sulfate, a uremic toxin, on the intracellular oxidation level and phagocytic activity using an HL-60-differentiated human macrophage cell model.
Tsutsumi S; Tokunaga Y; Shimizu S; Kinoshita H; Ono M; Kurogi K; Sakakibara Y; Suiko M; Liu MC; Yasuda S
Biosci Biotechnol Biochem; 2020 May; 84(5):1023-1029. PubMed ID: 31942834
[TBL] [Abstract][Full Text] [Related]
14. Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF-kappaB and free radical in proximal tubular cells.
Motojima M; Hosokawa A; Yamato H; Muraki T; Yoshioka T
Kidney Int; 2003 May; 63(5):1671-80. PubMed ID: 12675842
[TBL] [Abstract][Full Text] [Related]
15. A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia.
Lim CF; Bernard BF; de Jong M; Docter R; Krenning EP; Hennemann G
J Clin Endocrinol Metab; 1993 Feb; 76(2):318-24. PubMed ID: 8432774
[TBL] [Abstract][Full Text] [Related]
16. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair.
Dou L; Bertrand E; Cerini C; Faure V; Sampol J; Vanholder R; Berland Y; Brunet P
Kidney Int; 2004 Feb; 65(2):442-51. PubMed ID: 14717914
[TBL] [Abstract][Full Text] [Related]
17. Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques.
Sato E; Saigusa D; Mishima E; Uchida T; Miura D; Morikawa-Ichinose T; Kisu K; Sekimoto A; Saito R; Oe Y; Matsumoto Y; Tomioka Y; Mori T; Takahashi N; Sato H; Abe T; Niwa T; Ito S
Toxins (Basel); 2017 Dec; 10(1):. PubMed ID: 29283413
[TBL] [Abstract][Full Text] [Related]
18. Indoxyl sulfate upregulates the cannabinoid type 1 receptor gene via an ATF3/c-Jun complex-mediated signaling pathway in the model of uremic cardiomyopathy.
Hsu YJ; Hsu SC; Chang YL; Huang SM; Shih CC; Tsai CS; Lin CY
Int J Cardiol; 2018 Feb; 252():128-135. PubMed ID: 29203210
[TBL] [Abstract][Full Text] [Related]
19. Indoxyl Sulfate, a Uremic Toxin, Stimulates Reactive Oxygen Species Production and Erythrocyte Cell Death Supposedly by an Organic Anion Transporter 2 (OAT2) and NADPH Oxidase Activity-Dependent Pathways.
Dias GF; Bonan NB; Steiner TM; Tozoni SS; Rodrigues S; Nakao LS; Kuntsevich V; Pecoits Filho R; Kotanko P; Moreno-Amaral AN
Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 29976888
[TBL] [Abstract][Full Text] [Related]
20. Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production.
Itoh Y; Ezawa A; Kikuchi K; Tsuruta Y; Niwa T
Anal Bioanal Chem; 2012 Jun; 403(7):1841-50. PubMed ID: 22447217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
